Dr Roopal Desai
Clinical Fellow
University College London (UCL)
Dr Verena Zuber
Lecturer in Biostatistics
Imperial College London
Background
Literature review
Results and Discussion
MR study
Results and Discussion
Examining the Lancet Commission on risk factors for dementia using Mendelian Randomization
Combined PAF of 45%
Early-life risk factor
Education
Lancet Commission review
.
5
1
2
4
3
Risk factors
for
Dementia
Lancet Commission Risk Factors for Dementia
Mid-life risk factors
Hearing loss
Hypertension
Obesity
Alcohol*
TBI*
High LDL cholesterol**
Late-life risk factors
Smoking
Depression
Physical inactivity
Low Social Contact
Diabetes
Air Pollution*
Vision Loss**
Lancet Commission report 2024
Lancet Commission report 2020
Critique of Lancet Commission
Mendelian Randomization
Randomized control trial
Mendelian Randomization
Randomization
Random allocation of alleles
Intervention
Control
Effect allele
Control
Confounders equal between groups
Confounders equal between groups
Outcomes compared between groups
Outcomes compared between groups
What do MR studies tell us about modifiable risk factors and dementia?
What do MR studies tell us about modifiable risk factors and dementia?
What do MR studies tell us about modifiable risk factors and dementia?
What do MR studies tell us about modifiable risk factors and dementia?
What do MR studies tell us about modifiable risk factors and dementia?
What does all of this tell us?
Study design
Data sources
Mendelian randomization analysis
Sensitivity analyses
Methods
Results – Alzheimer’s Disease
Results – Dementia with Lewy Bodies
Results – Frontotemporal Dementia
Revisiting: Results – Alzheimer’s Disease
Protective effect of established risk factors
Open question: Why are some MR effect estimates of certain risk factors on dementia protective?
Birth Early life Mid life Late life
Average age of first heart attack
Average age of onset of dementia
0 65 80
Open discussion: How can we make MR more robust to survivor bias?
G
X1
X2
Y
U1
U2
Multivariable MR:
Aims:
IV selection: Based on genetic variants associated with any of the exposures
IV selection: Based on the primary exposure
Open discussion: How can we make MR more robust to survivor bias?
Multivariable MR:
Aims:
IV selection: Based on genetic variants associated with any of the exposures
IV selection: Based on the primary exposure
G
X1
X2
Y
U1
U2
Open discussion: How can we make MR more robust to survivor bias?
Multivariable MR implementation:
IV selection:
-> 219 independent genetic variants associated with blood pressure
G
Genetic variants associated with blood pressure
X1
Blood pressure
X2
Coronary artery disease
Y
U1
U2
Example: Are blood pressure and smoking protective?
Open discussion: How can we make MR more robust to survivor bias?
Limitations of multivariable MR to adjust for potential survivor bias:
Question: Which competing events are necessary to adjust for?
Other ways to tackle survivor bias in MR:
Discussion of Lancet Commission Risk Factors for Dementia
-> Call for better data and better methods
-> More efforts into triangulation using different methodologies and data sources